British researchers have developed a new Prostate Urine Risk (PUR) test that requires taking samples simply and easily at home, according to Medical Daily. The tests will reportedly check for specific biomarkers of prostate cancer in the urine and will be able to tell you five years in advance if you are going to develop aggressive prostate cancer and assess your risk factors.
"The most commonly used tests for prostate cancer include blood tests, a physical examination known as a digital rectal examination, an MRI scan and a biopsy or a biopsy," Jeremy Clark, one of the lead researchers from the University of East Anglia in England, said in a statement. "We developed the PUR test, which looks at gene expression in urine samples and provides vital information about whether a cancer is aggressive or low risk."
"Using our at-home test could in the future revolutionize how those on 'active surveillance' are monitored for disease progression, with men only having to visit a clinic for a positive urine test," Clark continued. "This is in contrast to the current situation where men are recalled every six to 12 months for painful and expensive biopsies."
The study participants said they much preferred the at-home tests over traditional methods that can be uncomfortable.
According to Dr. David Taub, a board-certified urologist in Boca Raton, Florida, prostate cancer is abnormal cell growth in the prostate gland. It is the second most common cancer in American men and the second most cause of cancer deaths in American men.
"The risk of the average man in the United States over the course of his lifetime to develop prostate cancer is one in eight," he tells Newsmax. "Risk factors include a strong family history, men who are BRCA gene carriers, and African-American men. All three categories are at risk for getting prostate cancer earlier as well as more aggressively."
According to ScienceDaily, the new urine test could revolutionize diagnosis and researchers hope that their findings also help pioneer the development of at-home collection tests for bladder or kidney cancer.
Dr. Herman Kattlove, M.D., former spokesperson for the American Cancer Society, tells Newsmax: "It is interesting that they will be looking for genetic markers of aggressive prostate cancer. There needs to be more studies that define these markers and then see if early detection of these markers in the urine will actually save lives."
© 2022 NewsmaxHealth. All rights reserved.